Gloria Wang | Executive Director, Clinical Development
Just Biotherapeutics | China

Gloria Wang, Executive Director, Clinical Development, Just Biotherapeutics

Dr. Yi (Gloria) Wang is Executive Director of Clinical Development in JUST Biotherapeutics Inc., China. She has more than 15 year’s experiences in clinical Development. She initiated her career in development medicine when she worked in Johns Hopkins Hospital. After entered the biopharmaceutical industry she worked in United Therapeutics and Novartis. Her footprint and hands-on experiences of clinical studies are in more than ten countries and areas located in America, Europe and Asia Pacific Area. She has Ph.D. from Fudan University and received her post-doctoral trainings in University of Massachusetts Medical School (UMASS).

Appearances:



Phar-East Day Two @ 11:10

Multi regional clinical trial (MRCT) harmonisation: An overview

This one hour session includes an overview presentation on MRCT in Asia, with quick 10-minute updates from Japan, Taiwan, Malaysia, Singapore and a combined 20 minutes panel session to discuss regulatory challenges from both regulator and pharma perspectives, successes so far and what can be expected in the year of 2020
 
11:00 Overview of MRCT in Asia
James Cai, VP Global Regulatory Affairs, Access & Policy, Amgen, China
 
11:10 ICH E17
Koichi Miyazaki, Senior Director, Regulatory Affairs, Asia Development Department, Daiichi Sankyo, Japan
 
11:20 Japan
Robert Bruno, Director, Clinical Program Development, Abbvie, Japan
 
11:30 Taiwan
I-Ning Tang, Senior Senior Reviewer, Center For Drug Evaluation, Taiwan
 
11:40 China
Gloria Wang, Executive Director, Clinical Development Just Biotherapeutics, China
 
11:50-12:30 Panel: Successes and future strategies to promote cross-country drug development
James Cai, VP Global Regulatory Affairs, Access & Policy, Amgen, China
I- Ning Tang, Senior Senior Reviewer, Center For Drug Evaluation, Taiwan
Robert Bruno, Director, Clinical Program Development, Abbvie, Japan
Gloria Wang, Executive Director, Clinical Development, Just Biotherapeutics, China
Koichi Miyazaki, Senior Director, Regulatory Affairs, Asia Development Department, Daiichi Sankyo, Japan

back to speakers